Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche

European Journal of Endocrinology

Volumn 147, Issue 4, 2002, Pages 485-488

  Potau, N ^a   Rique S ^a   Eduardo, I ^a   Marcos, V ^a   Ibanez L ^a  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; CYTOCHROME P450; GENOMIC DNA; GONADORELIN AGONIST; HORMONE BINDING PROTEIN; HYDROXYPROGESTERONE; INSULIN; LEUPRORELIN; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DNA EXTRACTION; ENDOCRINE DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE CLUSTER; GENE FREQUENCY; GENETIC CORRELATION; GENETIC DISORDER; GENOTYPE; HETEROZYGOTE DETECTION; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PRECOCIOUS PUBERTY; PREPUBERTY; PRIORITY JOURNAL; PROVOCATION TEST; PSEUDOGENE; SPLICEOSOME;

EID: 0036773532     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470485     Document Type: Article

References (38)

1. Ibáñez L, DiMartino-Nardi J, Potau N & Saenger P. Premature adrenarche - normal variant or forerunner of adult disease? Endocrine Reviews 2000 21 671-696.
2. Ibañez L, Bonnin MR, Zampolli M, Prat N, Alia PJ & Navarro MA. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche. Hormone Research 1995 44 51-56.
3. Machuca I, Ibáñez L, Bonnín MR, Rosel P, Arranz B & Navarro MA. Routine detection of point mutations in non-classic steroid 21-hydroxylase deficiency. International Journal of Clinical and Laboratory Research 1997 27 257-260.
4. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A & New MI. High frequency of non-classical steroid 21-hydroxylase deficiency. American Journal of Human Genetics 1985 31 650-667.
5. Siegel SF, Finegold DN, Urban MD, McVie R & Lee PA. Premature pubarche: etiological heterogeneity. Journal of Clinical Endocrinology and Metabolism 1992 74 239-247.
6. del Baizo P, Borrelli P, Gambiano P, Danielli E & Cappa M. Adrenal steroidogenic defects in children with precocious pubarche. Hormone Research 1992 37 180-184.
7. Ibáñez L, Potau N, Francois I & de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. Journal of Clinical Endocrinology and Metabolism 1998 83 3558-3662.
8. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P & Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. Journal of Clinical Endocrinology and Metabolism 1997 82 2283-2288.
9. Ibáñez L, Potau N, Chacón P. Pascual C & Carrascosa A. Hyperinsulinemia, dyslipemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998 41 1057-1063.
10. Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1993 76 1599-1603.
11. Ibáñez L, de Zegher F & Potau N. Anovulation after precocious pubarche: early markers and time course in adolescence. Journal of Clinical Endocrinology and Metabolism 1999 84 2691-2695.
12. Ibáñez L, Castell C, Tresserras R & Potau N. Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche. Clinical Endocrinology 1999 51 395-401.
13. Ibáñez L, Ong KO, Potau N, Marcos MV, de Zegher F & Dunger DB. Insulin gene VNTR genotype and the low birthweight, precocious pubarche and hyperinsulinism sequence. Journal of Clinical Endocrinology and Metabolism 2001 86 5788-5793.
14. Ibáñez L, Valls C, Potau N, Marcos MV & de Zegher F. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clinical Endocrinology 2001 55 667-672.
15. Dacou-Voutetakis C & Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. Journal of Clinical Endocrinology and Metabolism 1999 84 1570-1574.
16. Witchel SE, Lee PA, Sudahartman M & Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochemical and Molecular Medicine 1997 62 151-158.
17. Witchel SF, Smith R, Tomboc M & Aston CE. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertility and Sterility 2001 75 724-730.
18. Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in girls. Archives of Diseases in Childhood 1969 44 291-303.
19. Rosenfield RL. Normal and almost normal precocious variations in pubertal development. Premature pubarche and premature thelarche revisited. Hormone Research 1994 41 (Suppl 2) 7-13.
20. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE & Pollack MS. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. Journal of Clinical Endocrinology and Metabolism 1983 56 3320-3325.
21. Sakkal-Alkaddour H, Zhang L, Yang X, Chang YT, Kappy M, Slover RS et al. Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated Δ-5-steroid levels. Journal of Clinical Endocrinology and Metabolism 1996 81 3961-3965.
22. Ferriman D & Gallwey JD. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961 21 1440-1447.
23. Ibáñez L, Potau N, Zampolli M, Prat N, Gussinyé M, Saenger P et al. Source localization of androgen excess in adolescent girls. Journal of Clinical Endocrinology and Metabolism 1994 79 1778-1784.
24. Wedell A & Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Molecular Genetics 1993 2 499-504.
25. Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatrica 1998 87 159-164.
26. Potau N, Ibañez L, Riqué S & Carrascosa A. Pubertal changes in insulin secretion and peripheral insulin sensitivity. Hormone Research 1997 48 219-226.
27. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197.
28. Temeck JW, Pang S, Nelson C & New MI. Genetic defects of steroidogenesis in premature pubarche. Journal of Clinical Endocrinology and Metabolism 1987 64 609-617.
29. Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM & Mayes DM. Absence of nonclassical congenital hyperplasia in patients with precocious adrenarche. Journal of Clinical Endocrinology and Metabolism 1989 69 709-715.
30. August GP, Hung W & Mayes DM. Plasma androgens in premature pubarche: value of 17-hydroxyprogesterone in differentiation from congenital adrenal hyperplasia. Journal of Pediatrics 1975 87 246-249.
31. Oberfield SE, Mayes DM & Levine LS. Adrenal steroidogenic function in a black and Hispanic population with precocious pubarche. Journal of Clinical Endocrinology and Metabolism 1990 70 76-82.
32. Leite MV, Mendoncca BB, Arnhold IJ, Estefan V, Nunes C, Nicolau W et al. Identification of nonclassical 21-hydroxylase deficiency in girls with precocious adrenarche. Journal of Endocrinological Investigation 1991 14 11-15.
33. Ostlere LS, Rumsby G, Holowniat P, Jacobs HS, Rustin MHA & Honour JW. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clinical Endocrinology 1998 48 209-215.
34. Escobar-Monrreale HF, San Millán JL, Smith RR, Sancho J & Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertility and Sterility 1999 72 629-638.
35. White PC & Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 2000 21 245-291.
36. Blanché H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E et al. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Human Genetics 1997 101 56-60.
37. Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Mayers BA, Dewailly D & Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1997 82 479-485.
38. Strauss JF III & Dunaif A. Molecular mysteries of polycystic ovary syndrome. Molecular Endocrinology 1999 13 66-73.